Sitosterolemia in Iberoamerican countries: 16 new cases and phenotype genotype analysis
Journal of Clinical Lipidology · 2025
DOI: 10.1016/j.jacl.2025.08.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2025. Verfasst von Ana Catarina Alves und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion and Non-Communicable Diseases Prevention, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal (Dr Alve…. Hauptthemen laut MEDLINE: Hypercholesterolemia, Lipid Metabolism, Inborn Errors, Intestinal Diseases, Phytosterols. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Horizon 2020 Framework Programme, Navarra Government, EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions.
Abstract (Originalsprache)
BACKGROUND: Sitosterolemia is a rare autosomal recessive lipid disorder caused by biallelic pathogenic variants in ABCG5 or ABCG8 genes. It is characterized by elevated plasma plant sterol concentrations, xanthomas, and an increased risk of premature cardiovascular disease. As happens with familial hypercholesterolemia (FH), sitosterolemia is subdiagnosed and is frequently confounded with FH, resulting in inappropriate management. This study aims to describe newly identified cases across Iberoamerican countries and to highlight the need for improved diagnostic strategies. METHODS: We report 16 cases of molecularly confirmed sitosterolemia from 5 Iberoamerican countries (Argentina, Mexico, Portugal, Spain, and Uruguay), including 12 index cases and 4 relatives identified by cascade screening. Clinical, biochemical, and molecular data were collected and analyzed. β-sitosterol levels were measured when possible, and variant classification followed American College of Medical Genetics and Genomics (ACMG) guidelines with disease-specific adaptations. RESULTS: Fifteen individuals had biallelic variants in ABCG8 and 1 had a homozygous frameshift variant in ABCG5. Ten distinct ABCG8 variants were identified, including 7 nonsense and 3 missense variants. Xanthomas were observed in 56% of cases. Most cases were initially diagnosed as FH, with a diagnostic delay of up to 30 years. Treatment with ezetimibe, alone or combined with statins, led to biochemical and clinical improvement, including xanthoma regression in some cases. CONCLUSION: Sitosterolemia remains underdiagnosed due to lack of systematic screening and clinical overlap with FH. Our findings highlight the importance of including ABCG5/8 in genetic testing panels and of recognizing clinical clues for early diagnosis, enabling targeted treatment and prevention of adverse outcomes. Adapted ACMG variant classification improves interpretability for ABCG5/8-related sitosterolemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Promotion and Non-Communicable Diseases Prevention, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal (Dr Alves, Dr Chora, Miranda, Drs Medeiros, Graça, and Bourbon); Faculty of Sc…
- Department of Experimental Genetics, National Centre for Clinician Genetics, National Administration of Laboratories and Health Institutes "Dr. Carlos Malbrán", Buenos Aires, Argentina (Dr Bañares).
- Nutrition Service, National Paediatric Hospital "Dr JP Garraham", Buenos Aires, Argentina (Dr Araujo).
- Medicine, Bellvitge University Hospital, Barcelona, Spain (Dr Vilagut).
- Lipids and Atherosclerosis Unit, Internal Medicine Department, Santa Catarina de Salt Hospital, Salt, Girona, Spain (Drs Soler, Meavilla, Volpe).
- Internal Medicine, Lipids Unit, Virgen de la Victoria University Hospital, Institute of Biomedical Research (IBIMA), University of Malaga, Malaga, Spain (Drs Toledo and Valdivielso).
Förderung
- Horizon 2020 Framework Programme
- Navarra Government
- EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions
Zitieren
APA
Alves, A. C., Chora, J. R., Miranda, B., Medeiros, A. M., Graça, R., Bañares, V. G., Araujo, M. B., Vilagut, F. T., Soler, C., Meavilla, S., Toledo, M. J. B., Volpe, C. G., Reyes, X., Dell'Oca, N., Martins, P., Marado, D., Vilarinho, L., Dias, A. J., Ferreira, A. C., …, & Bourbon, M. (2025). Sitosterolemia in Iberoamerican countries: 16 new cases and phenotype genotype analysis. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2025.08.020
Vancouver
Alves AC, Chora JR, Miranda B, Medeiros AM, Graça R, Bañares VG, et al. Sitosterolemia in Iberoamerican countries: 16 new cases and phenotype genotype analysis. Journal of Clinical Lipidology. 2025. doi:10.1016/j.jacl.2025.08.020
BibTeX
@article{Alves2025,
author = {Alves, Ana Catarina and Chora, Joana Rita and Miranda, Beatriz and Medeiros, Ana Margarida and Graça, Rafael and Bañares, Virginia G and Araujo, Maria Beatriz and Vilagut, Ferrán Trías and Soler, Cristina and Meavilla, Silvia and Toledo, Maria J Benitez and Volpe, Camila Garcia and Reyes, Ximena and Dell'Oca, Nicolás and Martins, Paula and Marado, Diana and Vilarinho, Laura and Dias, Aureliano Jorge and Ferreira, Ana Cristina and Padeira, Gonçalo and Casañas, Marta and Alegre-González, Diana and Lozano, José Mosquera and Aguiar, Patrício and Gonçalves, Filipa Sousa and Ernaga, Ander and Apellaniz-Ruiz, Maria and Rubi, Rodrigo and Figueroa, Nahún Muñoz and Vasquez, Norma Alejandra and Valdivielso, Pedro and Bourbon, Mafalda},
title = {Sitosterolemia in Iberoamerican countries: 16 new cases and phenotype genotype analysis},
journal = {Journal of Clinical Lipidology},
year = {2025},
doi = {10.1016/j.jacl.2025.08.020}
}
EUVIMED